Elequin Capital LP Artivion, Inc. Transaction History
Elequin Capital LP
- $1.04 Billion
- Q1 2024
A detailed history of Elequin Capital LP transactions in Artivion, Inc. stock. As of the latest transaction made, Elequin Capital LP holds 26,270 shares of AORT stock, worth $663,842. This represents 0.05% of its overall portfolio holdings.
Number of Shares
26,270Holding current value
$663,842% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding AORT
# of Institutions
151Shares Held
34.9MCall Options Held
18KPut Options Held
1.5K-
Black Rock Inc. New York, NY6.74MShares$170 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.8MShares$70.7 Million0.07% of portfolio
-
Perceptive Advisors LLC New York, NY2.67MShares$67.4 Million1.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.66MShares$67.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.34MShares$59 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.02B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...